Ingevity Corp (NGVT) - Net Assets
Based on the latest financial reports, Ingevity Corp (NGVT) has net assets worth $38.90 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.65 Billion) and total liabilities ($1.61 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NGVT goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $38.90 Million |
| % of Total Assets | 2.36% |
| Annual Growth Rate | -18.14% |
| 5-Year Change | -95.59% |
| 10-Year Change | -77.93% |
| Growth Volatility | 53.5 |
Ingevity Corp - Net Assets Trend (2013–2025)
This chart illustrates how Ingevity Corp's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Ingevity Corp to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Ingevity Corp (2013–2025)
The table below shows the annual net assets of Ingevity Corp from 2013 to 2025. For live valuation and market cap data, see NGVT market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $29.70 Million | -84.78% |
| 2024-12-31 | $195.20 Million | -69.08% |
| 2023-12-31 | $631.40 Million | -9.58% |
| 2022-12-31 | $698.30 Million | +3.64% |
| 2021-12-31 | $673.80 Million | +4.09% |
| 2020-12-31 | $647.30 Million | +21.95% |
| 2019-12-31 | $530.80 Million | +56.30% |
| 2018-12-31 | $339.60 Million | +22.29% |
| 2017-12-31 | $277.70 Million | +106.32% |
| 2016-12-31 | $134.60 Million | -74.21% |
| 2015-12-31 | $522.00 Million | +24.29% |
| 2014-12-31 | $420.00 Million | +28.05% |
| 2013-12-31 | $328.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ingevity Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 40490000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $404.90 Million | 1363.30% |
| Common Stock | $400.00K | 1.35% |
| Other Comprehensive Income | $500.00K | 1.68% |
| Total Equity | $29.70 Million | 100.00% |
Ingevity Corp Competitors by Market Cap
The table below lists competitors of Ingevity Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Greatek Electronics Inc
TW:2441
|
$2.42 Billion |
|
Sopra Steria Group SA
PA:SOP
|
$2.42 Billion |
|
Calix Inc
NYSE:CALX
|
$2.42 Billion |
|
CESC Limited
NSE:CESC
|
$2.42 Billion |
|
TAV Havalimanlari Holding
IS:TAVHL
|
$2.42 Billion |
|
Aadhar Housing Finance Ltd
NSE:AADHARHFC
|
$2.42 Billion |
|
Clariant AG
SW:CLN
|
$2.41 Billion |
|
Wedge Industrial Co Ltd
SHE:000534
|
$2.41 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ingevity Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 195,200,000 to 29,700,000, a change of -165,500,000 (-84.8%).
- Net loss of 167,100,000 reduced equity.
- Share repurchases of 56,300,000 reduced equity.
- Other comprehensive income increased equity by 41,900,000.
- Other factors increased equity by 16,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-167.10 Million | -562.63% |
| Share Repurchases | $56.30 Million | -189.56% |
| Other Comprehensive Income | $41.90 Million | +141.08% |
| Other Changes | $16.00 Million | +53.87% |
| Total Change | $- | -84.78% |
Book Value vs Market Value Analysis
This analysis compares Ingevity Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 89.48x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 9.47x to 89.48x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $7.75 | $73.41 | x |
| 2014-12-31 | $9.91 | $73.41 | x |
| 2015-12-31 | $12.29 | $73.41 | x |
| 2016-12-31 | $3.18 | $73.41 | x |
| 2017-12-31 | $6.53 | $73.41 | x |
| 2018-12-31 | $7.97 | $73.41 | x |
| 2019-12-31 | $12.58 | $73.41 | x |
| 2020-12-31 | $15.58 | $73.41 | x |
| 2021-12-31 | $16.82 | $73.41 | x |
| 2022-12-31 | $18.15 | $73.41 | x |
| 2023-12-31 | $17.30 | $73.41 | x |
| 2024-12-31 | $5.37 | $73.41 | x |
| 2025-12-31 | $0.82 | $73.41 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ingevity Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -562.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -14.31%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 55.59x
- Recent ROE (-562.63%) is below the historical average (-36.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 36.50% | 12.14% | 1.65x | 1.82x | $86.40 Million |
| 2014 | 30.94% | 12.39% | 1.45x | 1.72x | $87.30 Million |
| 2015 | 15.47% | 8.26% | 1.24x | 1.51x | $28.30 Million |
| 2016 | 26.15% | 3.88% | 1.09x | 6.19x | $21.74 Million |
| 2017 | 45.48% | 12.99% | 1.05x | 3.35x | $98.53 Million |
| 2018 | 49.79% | 14.92% | 0.86x | 3.87x | $135.14 Million |
| 2019 | 34.61% | 14.21% | 0.60x | 4.04x | $130.62 Million |
| 2020 | 28.02% | 14.92% | 0.52x | 3.61x | $116.67 Million |
| 2021 | 17.53% | 8.49% | 0.56x | 3.66x | $50.72 Million |
| 2022 | 30.30% | 12.68% | 0.61x | 3.92x | $141.77 Million |
| 2023 | -0.86% | -0.32% | 0.65x | 4.15x | $-68.54 Million |
| 2024 | -220.44% | -30.60% | 0.70x | 10.36x | $-449.82 Million |
| 2025 | -562.63% | -14.31% | 0.71x | 55.59x | $-170.07 Million |
Industry Comparison
This section compares Ingevity Corp's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $769,114,085
- Average return on equity (ROE) among peers: 2.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ingevity Corp (NGVT) | $38.90 Million | 36.50% | 41.42x | $2.42 Billion |
| Albemarle Corp (ALB) | $517.34 Million | 15.46% | 0.72x | $18.76 Billion |
| Alto Ingredients Inc (ALTO) | $2.40 Million | -40.22% | 0.72x | $212.84 Million |
| Aemetis Inc (AMTX) | $-184.74 Million | 0.00% | 0.00x | $137.92 Million |
| Air Products and Chemicals Inc (APD) | $2.57 Billion | 16.16% | 1.53x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $2.87 Billion | 5.89% | 0.97x | $2.97 Billion |
| Avient Corp (AVNT) | $387.20 Million | 6.07% | 3.58x | $3.38 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.48 Billion | 8.22% | 3.84x | $6.23 Billion |
| Balchem Corporation (BCPC) | $2.80 Million | 14.29% | 1.07x | $5.17 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $-1.31K | 0.00% | 0.00x | $5.91 Million |
| Bon Natural Life Ltd (BON) | $44.35 Million | 0.90% | 0.39x | $7.43 Million |
About Ingevity Corp
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sell… Read more